Back
Speaker illustration

Miss Ines Vasconcelos

Faculty of Medicine University of Porto, Porto (Portugal)

Presentations

Urocortin-2 as a novel biomarker of clinical deterioration in HFpEF: a prospective cohort study

Event: Heart Failure 2024

Topic: Biomarkers

Session: Chronic heart failure - diagnostic methods 3

Access
Like
Thumbnail

Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction

Event: ESC Congress 2022

Topic: Heart Failure

Session: Pathomechanisms of heart failure with preserved ejection fraction

Access
Like
Thumbnail

Therapeutic effects of urocortin-2 in Heart Failure with preserved Ejection Fraction

Event: Heart Failure 2022

Topic: Heart Failure

Session: Basic & Translational Late-Breaking Science

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources